173 related articles for article (PubMed ID: 37657527)
1. Longitudinal assessment of bleomycin-induced pulmonary fibrosis by evaluating TGF-β1/Smad2, Nrf2 signaling and metabolomic analysis in mice.
Washimkar KR; Tomar MS; Kulkarni C; Verma S; Shrivastava A; Chattopadhyay N; Mugale MN
Life Sci; 2023 Oct; 331():122064. PubMed ID: 37657527
[TBL] [Abstract][Full Text] [Related]
2. Stevioside attenuates bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway and inhibiting the NF-κB and TGF-β1/Smad2/3 pathways.
Hao W; Yu TT; Zuo DZ; Hu HZ; Zhou PP
Exp Lung Res; 2023 Nov; 49(1):205-219. PubMed ID: 38044666
[No Abstract] [Full Text] [Related]
3. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways.
Tang H; Gao L; Mao J; He H; Liu J; Cai X; Lin H; Wu T
Cell Stress Chaperones; 2016 Mar; 21(2):239-49. PubMed ID: 26577463
[TBL] [Abstract][Full Text] [Related]
4. COX-2/sEH Dual Inhibitor PTUPB Attenuates Epithelial-Mesenchymal Transformation of Alveolar Epithelial Cells
Zhang CY; Guan XX; Song ZH; Jiang HL; Liu YB; Chen P; Duan JX; Zhou Y
Oxid Med Cell Longev; 2022; 2022():5759626. PubMed ID: 35509835
[TBL] [Abstract][Full Text] [Related]
5. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
6. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
7. Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition.
Zhou Y; He Z; Gao Y; Zheng R; Zhang X; Zhao L; Tan M
Front Pharmacol; 2016; 7():430. PubMed ID: 27895584
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis.
Zhang Z; Qu J; Zheng C; Zhang P; Zhou W; Cui W; Mo X; Li L; Xu L; Gao J
Cell Death Dis; 2018 Jan; 9(2):83. PubMed ID: 29362432
[TBL] [Abstract][Full Text] [Related]
9. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
10. S-allylmercapto-N-acetylcysteine ameliorates pulmonary fibrosis in mice via Nrf2 pathway activation and NF-κB, TGF-β1/Smad2/3 pathway suppression.
Zhang Q; Ye W; Liu Y; Niu D; Zhao X; Li G; Qu Y; Zhao Z
Biomed Pharmacother; 2023 Jan; 157():114018. PubMed ID: 36410121
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis.
Zhou W; Mo X; Cui W; Zhang Z; Li D; Li L; Xu L; Yao H; Gao J
Sci Rep; 2016 Dec; 6():38646. PubMed ID: 27982105
[TBL] [Abstract][Full Text] [Related]
12. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of HMGB1 is required for the protective role of Nrf2 in EMT-mediated PF.
Qu J; Zhang Z; Zhang P; Zheng C; Zhou W; Cui W; Xu L; Gao J
J Cell Physiol; 2019 Jun; 234(6):8862-8872. PubMed ID: 30370641
[TBL] [Abstract][Full Text] [Related]
15. Melatonin ameliorates bleomycin-induced pulmonary fibrosis via activating NRF2 and inhibiting galectin-3 expression.
Lan YJ; Cheng MH; Ji HM; Bi YQ; Han YY; Yang CY; Gu X; Gao J; Dong HL
Acta Pharmacol Sin; 2023 May; 44(5):1029-1037. PubMed ID: 36333557
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
17. Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/smad signaling pathway.
Sun Q; Hu J; Yu P; Zhu Z; Yu R; Ge C; Li C; Wu G; Lin B; Liu G; Liu M; Bian H; Xu H; Jia S
Exp Lung Res; 2019; 45(5-6):123-134. PubMed ID: 31210057
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
[TBL] [Abstract][Full Text] [Related]
20. Nickel induces epithelial-mesenchymal transition in pulmonary fibrosis in mice via activation of the oxidative stress-mediated TGF-β1/Smad signaling pathway.
Cao S; Yin H; Li X; Zeng X; Liu J
Environ Toxicol; 2024 Jun; 39(6):3597-3611. PubMed ID: 38488660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
